CSIMarket
 
Protagonist Therapeutics inc   (NASDAQ: PTGX)
Other Ticker:  
 
 

Protagonist Therapeutics Inc Growth Comparisons

Select each growth Category to receive further Information



PTGX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) - 9.75 % 7.3 % 3.85 %
Q / Q Revenue Growth (Q3 MRQ) 12.19 % 3.93 % 2.76 % 0.31 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) - 2.77 % 5.66 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 1.46 % 2.56 % 1.77 % 1.08 %
Revenue 5 Year Average Growth 14.17 % 8.81 % 7.98 % 7.77 %


PTGX's Growth Comparisons in III. Quarter 2024




Protagonist Therapeutics Inc reported top-line of $ 5 millions in the third quarter 2024, compare to $ 0 millions in the same quarter a year ago. Revenues in the Major Pharmaceutical Preparations industry grew by 9.75%, while the top-line in the Healthcare sector increased by 7.3%, and overall market improved by 3.85% from the third quarter 2023.

Top-line improved by 12.19% from the second quarter. Looking into annual sales rise of 14.17%, and S & P 500's average yearly sales growth is 7.77% over the five years, including only Businesses with the third quarter 2024 Results. Protagonist Therapeutics Inc grew faster than the market.

PTGX Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
Total
-
12.19 %


Growth Rates of PTGX's Income in the third quarter 2024


PTGX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - 90.42 % 80.05 % 4.22 %
Seq. Operating Income Change (Q3 MRQ) - 42.18 % 33.32 % -2.5 %
Y / Y Operating Income Growth (Q3 TTM) - -32.14 % -5.83 % 9.02 %
Seq. Operating Income Growth (Q3 TTM) -2.05 % 29.44 % 19.93 % 1.36 %
Operating Income 5 Year Avg. Change - 2.84 % 6.03 % 9.17 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - 161.72 % 285.84 % -1.75 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - 59.34 % 119.47 % -8.86 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - -1.76 % 26.31 % 8.51 %
Seq. Income from Cont. Ops. Change (Q3 TTM) 0.53 % 42.09 % 56.61 % -0.08 %
Income from Cont. Ops. 5 Year Avg. Change - -3.9 % -9.86 % 7.33 %

PTGX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - -39.13 % 8.01 % -6.44 %
Q / Q Net Income Growth (Q3 MRQ) - 59.12 % 133.05 % -6.89 %
Y / Y Net Income Change (Q3 TTM) - -41.18 % -10.96 % 4.96 %
Seq. Net Income Change (Q3 TTM) 0.53 % -26.14 % 2.56 % -1.41 %
Net Income 5 Year Avg. Growth - 4.26 % -3.49 % 7.48 %

PTGX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - 180.79 % 285.84 % -1.75 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - 56.64 % 119.47 % -8.86 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) 1.44 % - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth - -16.94 % -9.86 % 7.33 %



PTGX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - -34.7 % 8.01 % -6.44 %
Q / Q EPS Net Growth (Q3 MRQ) - 56.43 % 133.05 % -6.89 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) 1.56 % - - -6.16 %
EPS Net 5 Year Avg. Change - 4.26 % -3.49 % 7.48 %



Protagonist Therapeutics Inc reported bottom-line of $ -0.54 in the third quarter, compare to $ -0.58 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -34.7%, while Healthcare sector increased by 8.01%, and overall market declined by -6.44%.

The bottom-line improved by 12.19% from the second quarter. Looking into annual income per share rise of 14.17%, and S & P 500's average yearly income per share growth is 7.48% over the five years, including only Businesses with the third quarter 2024 earnings reports. Protagonist Therapeutics Inc grew faster than the market.

PTGX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 38.16 % 37.8 % -41.98 %
Seq. Free Cash Flow Change (Q3 MRQ) - 201.6 % 107.49 % -35.8 %
Y / Y Free Cash Flow Change (Q3 TTM) - 1 % 4.24 % 3.46 %
Seq. Free Cash Flow Change (Q3 TTM) -0.54 % 8.1 % 8.11 % -10.66 %
Free Cash Flow 5 Year Avg. Change - 11.97 % 7.07 % 11.98 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - -79.59 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Seq. Net Cash Flow Change (Q3 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - 0.02 % 10.04 % -33.52 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 91.83 % 1.99 % 1.51 % 2.82 %
Seq. Capital Expenditures Change (Q3 MRQ) 2667.86 % 9.65 % 5.72 % 3.24 %
Y / Y Capital Expenditures Change (Q3 TTM) 80.34 % 5.59 % 3.04 % 69.35 %
Seq. Capital Expenditures Change (Q3 TTM) 53.54 % 1.69 % 2.03 % -0.5 %
Capital Expenditures 5 Year Avg. Change 4.62 % 13.66 % 9.35 % 8.9 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com